Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| SEM | SELECT MEDICAL HOLDINGS CORP | 2025-10-30 17:59:40 | 14.58 | 0.38 | 2.68 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEM | 0001320414 | SELECT MEDICAL HOLDINGS CORP | US81619Q1058 | — | — | NYSE | 8060 | Services-Hospitals | 1231 | — | C/O SELECT MEDICAL CORP | MECHANICSBURG | PA | 17055 | UNITED STATES | US | 717-972-1100 | C/O SELECT MEDICAL CORP, MECHANICSBURG, PA, 17055 | C/O SELECT MEDICAL CORP, MECHANICSBURG, PA, 17055 | — | Healthcare | 1996 | David Chernow | 47,596 | http://www.selectmedical.com | 3,622,619,762 | 122,775,718 | 123,989,261 | Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange. | 2025-10-30 14:15:40 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 3,622,619,762 | 368,957,406 | 11.3398 | 128,962,850 | 601,358 | 0.4685 |
| 2023 | 3,253,662,356 | 892,388,931 | 37.7927 | 128,361,492 | 1,187,621 | 0.9339 |
| 2022 | 2,361,273,425 | -2,330,696,154 | -49.6742 | 127,173,871 | -6,710,946 | -5.0125 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michael F. Malatesta | Chief Financial Officer, Executive Vice President | 2023 | 534,363 | 377,979 | 564,000 | 0 | 49,902 | 1,526,244 |
| Martin F. Jackson | Chief Financial Officer, Executive Vice President | 2022 | 700,000 | — | 4,456,500 | 0 | 218,891 | 5,375,391 |
| David S. Chernow | Chief Executive Officer, President | 2022 | 995,000 | — | 7,427,500 | 0 | 357,979 | 8,780,479 |
| Robert A. Ortenzio | Executive Chairman, Co-Founder | 2022 | 995,000 | — | 7,427,500 | 0 | 415,825 | 8,838,325 |
| Rocco A. Ortenzio | Co-Founder, Vice Chairman | 2022 | 950,000 | — | 4,456,500 | 0 | 213,130 | 5,619,630 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 44,100 |
| 2023 | 54,600 |
| 2022 | 53,800 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 5,187,105,000 | 6,664,058,000 | 6,333,538,000 |
| Cost Of Revenue | 4,553,461,000 | 5,732,017,000 | 5,600,161,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 225,869,000 | 170,193,000 | 153,035,000 |
| Operating Expenses | 4,922,196,000 | 6,110,952,000 | 5,959,021,000 |
| Operating Income | 268,315,000 | 554,874,000 | 403,283,000 |
| Net Income | 214,038,000 | 243,491,000 | 158,994,000 |
| Earnings Per Share Basic | 1.66 | 1.91 | 1.23 |
| Earnings Per Share Diluted | 1.66 | 1.91 | 1.23 |
| Weighted Average Shares Outstanding Basic | 124,614,000 | 123,105,000 | 124,628,000 |
| Weighted Average Shares Outstanding Diluted | 124,614,000 | 123,105,000 | 124,628,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 59,694,000 | 84,006,000 | 97,906,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 821,385,000 | 940,335,000 | 941,312,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 112,097,000 | 151,617,000 | 125,370,000 |
| Total Assets Current | 1,019,777,000 | 1,257,646,000 | 1,271,313,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | — | 1,023,561,000 | 1,001,440,000 |
| Other Assets Non Current | 372,813,000 | 376,722,000 | 341,738,000 |
| Total Assets Non Current | 522,412,000 | 523,762,000 | 381,533,000 |
| Total Assets | 5,607,951,000 | 7,689,631,000 | 7,665,293,000 |
| Accounts Payable | 142,157,000 | 174,312,000 | 186,729,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 20,269,000 | 70,329,000 | 44,351,000 |
| Other Liabilities Current | 59,000,000 | 161,800,000 | — |
| Total Liabilities Current | 977,651,000 | 1,248,465,000 | 1,155,151,000 |
| Long Term Debt | 1,691,546,000 | 3,587,675,000 | 3,835,211,000 |
| Other Liabilities Non Current | 73,038,000 | 110,303,000 | 106,137,000 |
| Total Liabilities Non Current | 213,345,000 | 225,209,000 | 108,629,000 |
| Total Liabilities | 3,610,856,000 | 6,115,616,000 | 6,274,686,000 |
| Common Stock | 129,000 | 128,000 | 127,000 |
| Retained Earnings | 770,146,000 | 751,856,000 | 581,010,000 |
| Accumulated Other Comprehensive Income | 0 | 42,907,000 | 88,602,000 |
| Total Shareholders Equity | 1,681,355,000 | 1,288,304,000 | 1,121,922,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 203,894,000 | 208,742,000 | 205,825,000 |
| Share Based Compensation Expense | 100,670,000 | 43,809,000 | 37,755,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 95,845,000 | -1,156,000 | 52,183,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -16,789,000 | -6,412,000 | -48,042,000 |
| Change In Other Liabilities | 26,492,000 | 84,095,000 | 12,839,000 |
| Cash From Operating Activities | 517,864,000 | 582,058,000 | 284,825,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 222,177,000 | 229,200,000 | 190,372,000 |
| Acquisition Of Business | 13,097,000 | 29,567,000 | 26,987,000 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -231,011,000 | -268,477,000 | -226,339,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 64,617,000 | 63,904,000 | 64,589,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 1,176,598,000 | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -311,165,000 | -327,481,000 | -34,890,000 |
| Change In Cash | -24,312,000 | -13,900,000 | 23,596,000 |
| Cash At End Of Period | 59,694,000 | 84,006,000 | 97,906,000 |
| Income Taxes Paid | 133,187,000 | 88,510,000 | 32,290,000 |
| Interest Paid | 256,229,000 | 272,261,000 | 183,453,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 1.66 | 1.91 | 1.23 |
| Price To Earnings Ratio | 11.3554 | 6.4697 | 10.6151 |
| Earnings Growth Rate | -13.089 | 55.2846 | -58.7248 |
| Price Earnings To Growth Ratio | -0.8676 | 0.117 | -0.1808 |
| Book Value Per Share | 16.0262 | 12.786 | 11.1581 |
| Price To Book Ratio | 1.1762 | 0.9665 | 1.1701 |
| Ebitda | 679,724,000 | 739,382,000 | 566,220,000 |
| Enterprise Value | 4,001,094,900 | 5,095,231,106 | 5,408,873,944.8 |
| Dividend Yield | 0.0275 | 0.042 | 0.0397 |
| Dividend Payout Ratio | 0.3019 | 0.2624 | 0.4062 |
| Debt To Equity Ratio | 1.0181 | 2.8394 | 3.458 |
| Capital Expenditures | — | 230,863,000 | 245,798,000 |
| Free Cash Flow | — | 351,195,000 | 39,027,000 |
| Return On Equity | 0.1273 | 0.189 | 0.1417 |
| One Year Beta | 1.1842 | 1.0897 | 1.1041 |
| Three Year Beta | 1.1086 | 1.1388 | 1.4349 |
| Five Year Beta | 1.3883 | 1.3702 | 1.3132 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Weigl Christopher | CHIEF ACCOUNTING OFFICER | 2025-10-28 | 20,000 | A | 54,254 |
| Frist William H. | Director | 2025-10-28 | 1,266 | A | 304,063 |
| Duggan John F. | Executive Vice President | 2025-10-28 | 50,000 | A | 199,575 |
| Rusignuolo Brian R. | Chief Information Officer | 2025-08-01 | 14,680 | D | 361,370 |
| CHERNOW DAVID S | Director, CEO | 2025-08-01 | 49,100 | D | 892,830 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Jim Cooper | 2015-09-17 | TN05 | Sale | 2014-08-06 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2025-09-30 | 194,810 | 15,172 | 12.8401 |
| Parkside Financial Bank & Trust | 2025-09-30 | 861 | 67 | 12.8507 |
| STRS OHIO | 2025-09-30 | 639,432 | 49,800 | 12.84 |
| Covestor Ltd | 2025-09-30 | 200,000 | 15,538 | 12.8717 |
| BAILARD, INC. | 2025-09-30 | 427,572 | 33,300 | 12.84 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| SHELTON FUNDS | 2025-08-31 | K Shares | SMLKX | 4,113 | 53,510.13 | 0.1035 |
| SHELTON FUNDS | 2025-08-31 | Investor Shares | SMCIX | 4,113 | 53,510.13 | 0.1035 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Multi-Asset Real Return Fund - Class A | SEIAX | 1,118 | 14,545.18 | 0.0019 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Extended Market Index Fund - Class A | SMXAX | 15,765 | 205,102.65 | 0.0169 |
| Northern Lights Fund Trust IV | 2025-08-31 | Inspire Small/Mid Cap ETF | ISMD | 26,287 | 341,993.87 | 0.1555 |